#generic-drugs
#generic-drugs
[ follow ]
#mifepristone #fda-approval #drug-pricing #fda #abortion-policy #abortion-politics #induced-infringement
fromFlowingData
3 weeks agoWhere generic medication comes from
When generic drug manufacturers have issues like contamination, it is difficult for those who take the medications to know if they are affected. There is no standardized way to look up the data for where the pills in your bottle came from. ProPublica made an app that makes the lookup more straightforward. Even though generic drugs make up 90% of prescriptions dispensed in the U.S., the FDA only provides piecemeal information about them.
Public health
Intellectual property law
fromPatently-O
1 month agoLabel-Plus Liability: The Government Warns the Federal Circuit Misread Hatch-Waxman
The Solicitor General urges Supreme Court review to clarify that FDA-compliant skinny labels and basic commercial statements should not automatically constitute inducement of patent infringement.
fromwww.aljazeera.com
4 months agoWHO adds weight-loss, diabetes drugs to essential medicines list
The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs the WHO believes should be available in all functioning health systems. The new editions of essential medicines lists mark a significant step toward expanding access to new medicines with proven clinical benefits and with high potential for global public health impact, said Yukiko Nakatani, WHO's assistant director-general for Health Systems, Access and Data.
Public health
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
7 months agoSCOTUS Asks SG for Input on Petition Seeking to Clarify Inducement Under Hatch-Waxman
Hikma argues that the CAFC's ruling threatens generic drug access and deviates from established legal precedent on inducement.
Intellectual property law
fromIPWatchdog.com | Patents & Intellectual Property Law
8 months agoFTC Renews Campaign to Remove 'Junk' Inhaler and Device Patents from Orange Book Listings
FTC's warning letters may lead to extended litigation over patent listings.
The agency aims to improve access to generic drugs by challenging patents.
Targeted patents in the pharmaceutical sector are under scrutiny.
Efforts continue irrespective of longstanding industry calls for clearer guidelines.
fromIPWatchdog.com | Patents & Intellectual Property Law
9 months agoCAFC Affirms District Court Holding for Generic, Says Later-Made Prosecution Statements Don't Change Earlier Disclaimer
Judging these circumstances through the lens of public notice, Azurity's unilateral and belated statement carries no weight.
Beer
[ Load more ]